
Zenshine Biotech
至善唯新
Zenshine Biotech
Biotech/Healthcare
Founded in 2018, Zhishan Weixin is a leading Chinese gene therapy company focused on the development and disruptive manufacturing of rAAV-based gene therapies. Its pipeline covers hematologic disorders, rare diseases, and other therapeutic areas.
Latest round: Series B Extension (2025)
Source: ChinaBulls — chinabulls.com
Last updated 2025-12-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.